Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

4026–4050 of 5062

HighFDA (Drugs)·D-0757-2022·2022-04-13
Accuretic Blood Pressure Tablets Recalled for Excess Chemical Impurity
Pfizer is recalling Accuretic blood pressure tablets due to manufacturing deviations that resulted in N-nitroso chemical impurities exceeding safe intake limits. Patients should contact their pharmacist or physician.
Product
Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/25 mg, 90 tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0223-23.
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0770-2022·2022-04-13
Ophthalmic drug recalled for subpotency and particulate matter
Sun Pharmaceutical recalls CEQUA cyclosporine ophthalmic solution nationwide due to low assay results and particulate matter found in specific lots.
Product
CEQUA — CEQUA (CYCLOSPORINE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0751-2022·2022-04-13
Oral antiseptic rinse recalled due to label mix-up and wrong barcode
The Natural Dentist Healthy Breath Antiseptic Rinse (Cool Mint) is being recalled due to a label mix-up. The back label incorrectly states the active ingredient as Peppermint Oil and Sage Oil and displays the wrong UPC code.
Product
The Natural Dentist Healthy Breath Antiseptic Rinse, Cool Mint, 16.9 FL OZ (500 mL, Manufactured for Revive Personal Products Company, Madison, NJ 07940, UPC Code 714132000714.
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0749-2022·2022-04-13
Sucralfate Oral Suspension Recalled Due to Label Mix-Up
DASH Pharmaceuticals is recalling Sucralfate Oral Suspension nationwide due to a labeling mix-up affecting approximately 45,940 unit dose cups.
Product
Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0758-2022·2022-04-13
Quinapril and Hydrochlorothiazide Tablets Recalled for Elevated Chemical Impurity
Pfizer is recalling quinapril and hydrochlorothiazide tablets (20 mg/25 mg) nationwide due to elevated chemical impurities exceeding acceptable daily intake limits. No illnesses have been reported.
Product
quinapril and hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-5225-9
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0747-2022·2022-04-13
NETSPOT prescription drug kit recalled for subpotency in vial 1
Advanced Accelerator Applications recalls approximately 14,089 NETSPOT kits distributed nationwide due to subpotency detected during stability studies. The affected lots contain insufficient active ingredient concentration.
Product
NETSPOT — NETSPOT (68GA-DOTATATE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0762-2022·2022-04-13
Risedronate Sodium Tablets Recalled for Failed Content Uniformity Specifications
Macleods Pharma USA Inc is recalling Risedronate Sodium 5 mg tablets (Lot BRD2001A, expiration 5/2022) due to failed content uniformity specifications. The recall affects 4,872 bottles distributed nationwide.
Product
RISEDRONATE SODIUM — RISEDRONATE SODIUM (RISEDRONATE SODIUM)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0752-2022·2022-04-13
FDA Voluntary Recall of Methylprednisolone Tablets for Subpotency
Jubilant Cadista Pharmaceuticals is recalling Methylprednisolone Tablets USP 4mg because they contain less active ingredient than labeled. Lot 21 P0322 was distributed nationwide and in Puerto Rico.
Product
Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0745-2022·2022-04-13
Sodium Chloride Injection with Incorrect Barcode Labeling Recalled Nationwide
Ritedose is recalling 3,795 prefilled syringes of sodium chloride injection nationwide. The barcodes incorrectly identify the product as rocuronium bromide, creating a medication identification risk in healthcare settings.
Product
23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring, Rx Only, RITEDOSE, 503B Outsourcing Facility, A Division of the RITEDOSE Corporation, 1 Technology Circle, Columbia, SC 29203, 1-866-994-4670, NDC: 65302-509-30, barcode N (01) 003 65302 50930
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0767-2022·2022-04-06
Meclizine Hydrochloride Tablets Recalled Due to Incorrect Label Mix-up
Jubilant Cadista Pharmaceuticals recalls Meclizine Hydrochloride Tablets with incorrect labeling. Bottles labeled as PredniSONE contain Meclizine, risking medication errors.
Product
MECLIZINE HYDROCHLORIDE — MECLIZINE HYDROCHLORIDE (MECLIZINE HYDROCLORIDE)
Category
Drug
Distribution
0 states
HighFDA (Drugs)·D-0728-2022·2022-04-06
FDA Recalls Gonadorelin Injectable Vials for Lack of Sterility Assurance
Drug Depot, Inc. is recalling Gonadorelin 0.2 mg/mL injectable vials distributed nationwide due to lack of sterility assurance. Approximately 6,017 vials are affected.
Product
GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID132227, APS Pharmacy
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0736-2022·2022-04-06
Glycopyrrolate Tablets Recalled Due to Glass Pieces in Sealed Bottles
Aurolife Pharma is recalling Glycopyrrolate Tablets after glass fragments were discovered in a sealed bottle from packaging equipment. Approximately 4,080 bottles were distributed nationwide and in Puerto Rico.
Product
GLYCOPYRROLATE — GLYCOPYRROLATE (GLYCOPYRROLATE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0735-2022·2022-04-06
Testosterone Cypionate Injectable Recalled for Lack of Sterility Assurance
Drug Depot recalled 17 vials of Testosterone Cypionate Injectable due to lack of sterility assurance in manufacturing. The recalled product was distributed nationwide and should not be used.
Product
TESTOSTERONE CYPIONATE *GS* (2 mL) 80 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 127492, APS Pharmacy
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0733-2022·2022-04-06
Injectable Testosterone Recalled Due to Lack of Sterility Assurance
Drug Depot's testosterone injection product was recalled nationwide for lack of sterility assurance. Affected consumers should discontinue use and consult their healthcare provider.
Product
TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil (10 ML) 160MG/20MG/ML Injectable, Packaged in a multi dose 10ml vial, Formula ID 115498, APS Pharmacy
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0729-2022·2022-04-06
Gonadorelin injectable recalled for lack of sterility assurance
Drug Depot recalls 1,843 vials of Gonadorelin injectable nationwide due to lack of sterility assurance. Patients should consult their healthcare provider regarding previously dispensed doses.
Product
(CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID136345, APS Pharmacy
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0731-2022·2022-04-06
Testosterone Cypionate/Anastrozole Injectable Recalled for Sterility Assurance Defect
APS Pharmacy is recalling 73 vials of Testosterone Cypionate/Anastrozole oil due to lack of sterility assurance. The product was distributed nationwide including Puerto Rico.
Product
TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0734-2022·2022-04-06
Testosterone Cypionate Injectable Vials Recalled for Lack of Sterility Assurance
Drug Depot, Inc. is recalling 24 vials of Testosterone Cypionate 200 MG/ML Injectable nationwide due to lack of sterility assurance. The product was distributed throughout the USA and Puerto Rico.
Product
TESTOSTERONE CYPIONATE *GS* Oil 200 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 76681, APS Pharmacy
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0732-2022·2022-04-06
Testosterone Cypionate Injectable Recalled Due to Lack of Sterility Assurance
Drug Depot, Inc. is recalling 620 vials of Testosterone Cypionate/DHEA injectables due to lack of sterility assurance in manufacturing. The product was distributed nationwide.
Product
TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678; b) 10 ML Formula ID 115498, APS Pharmacy
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0730-2022·2022-04-06
Injectable testosterone-anastrozole mixture recalled for sterility assurance failure
Drug Depot (APS Pharmacy) is recalling testosterone cypionate/anastrozole injectable oil due to lack of sterility assurance. The recall affects 846 vials distributed nationwide.
Product
TESTOSTERONE CYPIONATE/ANASTROZOLE *GS* OIL 200MG/1MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 4 ML Formula ID 115387; b) (RM) 10 ML Formula ID 115125; APS Pharmacy
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0737-2022·2022-04-06
Lansoprazole Capsules Recalled for Failed Dissolution in Stability Testing
Dr. Reddy's Laboratories is recalling specific lots of Lansoprazole 15 mg delayed-release capsules nationwide because the capsules failed to dissolve properly during long-term stability testing, which could affect medication effectiveness.
Product
LANSOPRAZOLE — LANSOPRAZOLE (LANSOPRAZOLE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0738-2022·2022-04-06
Lansoprazole Delayed-Release Capsules Recalled for Failed Dissolution Specifications
Dr. Reddy's Laboratories is recalling 7,703 bottles of Lansoprazole Delayed-Release Capsules (30 mg, 90-count) nationwide due to failed dissolution specifications found during long-term stability testing.
Product
LANSOPRAZOLE — LANSOPRAZOLE (LANSOPRAZOLE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0726-2022·2022-04-06
Prescription Atorvastatin Calcium Tablets Recalled for Failed Quality Specifications
Dr. Reddy's Laboratories is recalling 28,068 bottles of Atorvastatin Calcium 80 mg tablets nationwide due to failed impurity and degradation specifications. No illnesses or injuries have been reported.
Product
ATORVASTATIN CALCIUM — ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0727-2022·2022-04-06
Clotrimazole and Betamethasone Topical Cream Recalled for Failed Potency Specifications
Taro Pharmaceuticals recalls Clotrimazole and Betamethasone Dipropionate cream after a stability sample failed potency testing. The recall affects 768 tubes distributed to a retailer in New York, expiring June 2023. No illnesses have been reported.
Product
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-0724-2022·2022-03-30
Sincalide Injection Recalled for Potency and Reconstitution Issues
Olympia Compounding Pharmacy is recalling Sincalide lyophilized powder for injection due to concerns about super potency and failed reconstitution time. The product is distributed nationwide, including Puerto Rico.
Product
Sincalide Lyophilized powder for reconstitution Each ML contains: Mannitol 170mg, Arginine 30mg, Lysine 15mg, Potassium Phosphate 9mg, Methionine 4mg, Edetate Disodium Dihydrate 2mg, Polysorbate mcg, Water for Injection, Multiple Dose Injection 5 mcg Vial, Rx Only, Olympia Compou
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0750-2022·2022-03-30
Fresenius Kabi Sodium Acetate Injection Recalled for Particulate Matter
Fresenius Kabi USA is recalling sodium acetate injection due to the presence of particulate matter composed of carbon, oxygen, iron, and trace elements in multiple lots distributed nationwide.
Product
SODIUM ACETATE — SODIUM ACETATE (SODIUM ACETATE)
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

4026–4050 of 5062